This disrupts the normal flow of lymph through the affected area, which may lead to an abnormal buildup of lymph fluid that can cause swelling
93 Collectively, these experimental tumors provide evidence not for a direct tumor growth-suppressing effect of insulin but indirect effects such as an influence on metabolic growth-promoting substrates whose global abundance is controlled by insulin
In phase II clinical trials involving obese individuals, tesofensine showed dose-dependent reductions in body weight, body fat, and waist circumference
78-LB: Efficacy and Safety of Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, Compared With Insulin Degludec in Patients With Type 2 Diabetes (SURPASS-3)
The PlexusDx Education Hub lays out GLP-1 pricing and coverage in everyday language
SURMOUNT-4 then followed patients after a treatment switch to measure maintenance